Medigen gets funds from global foundation for mix-and-match booster trials
12/02/2021 10:51 PM
Taiwanese pharmaceutical company Medigen Vaccine Biologics Corp. said Thursday that it has received a US$2.3 million grant from an international foundation to fund trials of its COVID-19 vaccine as a potential booster.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Cool, wet weather to persist in northern Taiwan over holiday weekend: CWA
10/23/2025 11:59 AM - Business
U.S. dollar up in Taipei trading
10/23/2025 10:26 AM - Business
Taiwan shares open lower
10/23/2025 09:08 AM - Society
Taiwan headline news
10/23/2025 08:44 AM - Sports
Taiwanese athletes vie for medals at Asian Youth Games in Bahrain
10/22/2025 09:48 PM